Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Thromboembolic events in patients with severe inherited fibrinogen deficiency.

Rottenstreich A, Lask A, Schliamser L, Zivelin A, Seligsohn U, Kalish Y.

J Thromb Thrombolysis. 2016 Aug;42(2):261-6. doi: 10.1007/s11239-015-1325-0.

PMID:
26712130
2.

The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency.

Livnat T, Shenkman B, Martinowitz U, Zivelin A, Dardik R, Tamarin I, Mansharov R, Budnik I, Salomon O.

Thromb Res. 2015 Aug;136(2):465-73. doi: 10.1016/j.thromres.2015.06.025. Epub 2015 Jun 19.

PMID:
26160656
3.

Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.

Livnat T, Martinowitz U, Azar-Avivi S, Zivelin A, Brutman-Barazani T, Lubetsky A, Kenet G.

Haemophilia. 2013 Sep;19(5):782-9. doi: 10.1111/hae.12181. Epub 2013 May 10.

PMID:
23659442
4.

Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews.

Peretz H, Salomon O, Mor-Cohen R, Usher S, Zucker M, Zivelin A, Seligsohn U.

J Thromb Haemost. 2013 Apr;11(4):724-30. doi: 10.1111/jth.12137.

5.

Severe factor X deficiency in three unrelated Palestinian patients is caused by homozygosity for the mutation c302delG-correlation with thrombin generation and thromboelastometry.

Livnat T, Shenkman B, Kenet G, Tamarin I, Gillis S, Varon D, Iijima K, Zivelin A, Salomon O.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):673-9. doi: 10.1097/MBC.0b013e32834ad785.

PMID:
22008904
6.

Point mutations regarded as missense mutations cause splicing defects in the factor XI gene.

Zucker M, Rosenberg N, Peretz H, Green D, Bauduer F, Zivelin A, Seligsohn U.

J Thromb Haemost. 2011 Oct;9(10):1977-84. doi: 10.1111/j.1538-7836.2011.04426.x.

7.

A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor.

Livnat T, Martinowitz U, Zivelin A, Rima D, Kenet G.

Thromb Haemost. 2011 Apr;105(4):688-95. doi: 10.1160/TH10-08-0542. Epub 2011 Jan 12.

PMID:
21225093
8.

Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis.

Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, Seligsohn U.

Thromb Haemost. 2011 Feb;105(2):269-73. doi: 10.1160/TH10-05-0307. Epub 2010 Nov 5.

PMID:
21057700
9.

[Laboratory evaluation of lupus anticoagulant in Israel].

Sarig G, Garach-Jehoshua O, Deutch V, Winder A, Hyam E, Katz BZ, Lahav J, Cassel A, Zivelin A, Souroujon M, Shimron O; Israeli Sub-Committee of Thrombosis and Hemostasis Laboratories.

Harefuah. 2010 May;149(5):288-90, 336. Hebrew.

PMID:
20941871
10.

Risk factors for failure of heparin thromboprophylaxis in patients with acute traumatic spinal cord injury.

Rubin-Asher D, Zeilig G, Ratner A, Asher I, Zivelin A, Seligsohn U, Lubetsky A.

Thromb Res. 2010 Jun;125(6):501-4. doi: 10.1016/j.thromres.2009.09.012. Epub 2009 Oct 23.

PMID:
19853891
11.

Thrombin generation assay as a possible tool for assessment of reduced activity of clotting factors induced by antiphospholipid antibodies and in-vitro evaluation of treatment options.

Livnat T, Zivelin A, Tamarin I, Guetta V, Salomon O.

Blood Coagul Fibrinolysis. 2009 Dec;20(8):661-6. doi: 10.1097/MBC.0b013e32832ff595.

PMID:
19730246
12.

Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI.

Zucker M, Zivelin A, Landau M, Rosenberg N, Seligsohn U.

J Thromb Haemost. 2009 Jun;7(6):970-5. doi: 10.1111/j.1538-7836.2009.03353.x.

13.

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors.

Martinowitz U, Livnat T, Zivelin A, Kenet G.

Haemophilia. 2009 Jul;15(4):904-10. doi: 10.1111/j.1365-2516.2009.02028.x. Epub 2009 Apr 7.

PMID:
19473416
14.

Familial factor VII deficiency with foetal and neonatal fatal cerebral haemorrhage associated with homozygosis to Gly180Arg mutation.

Landau D, Rosenberg N, Zivelin A, Staretz-Chacham O, Kapelushnik J.

Haemophilia. 2009 May;15(3):774-8. doi: 10.1111/j.1365-2516.2009.02004.x.

PMID:
19432927
15.

Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma.

Livnat T, Martinowitz U, Zivelin A, Seligsohn U.

Haemophilia. 2008 Jul;14(4):782-6. doi: 10.1111/j.1365-2516.2008.01688.x. Epub 2008 Mar 21.

PMID:
18371162
16.

Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulin.

Zucker M, Zivelin A, Teitel J, Seligsohn U.

Blood. 2008 Feb 1;111(3):1306-8. Epub 2007 Nov 20.

PMID:
18029554
17.

Characterization of seven novel mutations causing factor XI deficiency.

Zucker M, Zivelin A, Landau M, Salomon O, Kenet G, Bauduer F, Samama M, Conard J, Denninger MH, Hani AS, Berruyer M, Feinstein D, Seligsohn U.

Haematologica. 2007 Oct;92(10):1375-80.

18.

Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations.

Mor-Cohen R, Zivelin A, Fromovich-Amit Y, Kovalski V, Rosenberg N, Seligsohn U.

Blood Coagul Fibrinolysis. 2007 Mar;18(2):139-44.

PMID:
17287630
19.

Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago.

Zivelin A, Mor-Cohen R, Kovalsky V, Kornbrot N, Conard J, Peyvandi F, Kyrle PA, Bertina R, Peyvandi F, Emmerich J, Seligsohn U.

Blood. 2006 Jun 15;107(12):4666-8. Epub 2006 Feb 21.

PMID:
16493002
20.

Inhibitors to Factor XI in patients with severe Factor XI deficiency.

Salomon O, Zivelin A, Livnat T, Seligsohn U.

Semin Hematol. 2006 Jan;43(1 Suppl 1):S10-2. Review.

PMID:
16427373
21.

Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.

Livnat T, Zivelin A, Martinowitz U, Salomon O, Seligsohn U.

J Thromb Haemost. 2006 Jan;4(1):192-200.

22.

Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation.

Fromovich-Amit Y, Zivelin A, Rosenberg N, Landau M, Rosa JP, Seligsohn U.

Blood Coagul Fibrinolysis. 2005 Jul;16(5):369-74.

PMID:
15970722
23.

A novel ancestral splicing mutation in the multidrug resistance protein 2 gene causes Dubin-Johnson syndrome in Ashkenazi Jewish patients.

Mor-Cohen R, Zivelin A, Rosenberg N, Goldberg I, Seligsohn U.

Hepatol Res. 2005 Feb;31(2):104-11.

PMID:
15777714
24.

Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency.

Salomon O, Steinberg DM, Tamarin I, Zivelin A, Seligsohn U.

Blood Coagul Fibrinolysis. 2005 Jan;16(1):37-41.

PMID:
15650544
25.

Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families.

Vysokovsky A, Saxena R, Landau M, Zivelin A, Eskaraev R, Rosenberg N, Seligsohn U, Inbal A.

J Thromb Haemost. 2004 Oct;2(10):1790-7.

26.

Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation.

Zivelin A, Ogawa T, Bulvik S, Landau M, Toomey JR, Lane J, Seligsohn U, Gailani D.

J Thromb Haemost. 2004 Oct;2(10):1782-9.

27.

Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients.

Fromovich-Amit Y, Zivelin A, Rosenberg N, Tamary H, Landau M, Seligsohn U.

J Thromb Haemost. 2004 Oct;2(10):1774-81.

28.

Do platelets synthesize factor XI?

Gailani D, Zivelin A, Sinha D, Walsh PN.

J Thromb Haemost. 2004 Oct;2(10):1709-12. Review. No abstract available.

29.

A mutation in LMAN1 (ERGIC-53) causing combined factor V and factor VIII deficiency is prevalent in Jews originating from the island of Djerba in Tunisia.

Segal A, Zivelin A, Rosenberg N, Ginsburg D, Shpilberg O, Seligsohn U.

Blood Coagul Fibrinolysis. 2004 Jan;15(1):99-102.

PMID:
15166951
30.

A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency.

Bolton-Maggs PH, Peretz H, Butler R, Mountford R, Keeney S, Zacharski L, Zivelin A, Seligsohn U.

J Thromb Haemost. 2004 Jun;2(6):918-24.

31.

The prevalence of factor V G1691A but not of prothrombin G20210A and methylenetetrahydrofolate reductase C677T is remarkably low in French Basques.

Bauduer F, Zivelin A, Ducout L, Shpringer E, Seligsohn U.

J Thromb Haemost. 2004 Feb;2(2):361-2. No abstract available.

32.

High prevalences of vitamin B12 and folic acid deficiency in elderly subjects in Israel.

Figlin E, Chetrit A, Shahar A, Shpilberg O, Zivelin A, Rosenberg N, Brok-Simoni F, Gadoth N, Sela BA, Seligsohn U.

Br J Haematol. 2003 Nov;123(4):696-701.

PMID:
14616975
33.

Inherited factor XI deficiency confers no protection against acute myocardial infarction.

Salomon O, Steinberg DM, Dardik R, Rosenberg N, Zivelin A, Tamarin I, Ravid B, Berliner S, Seligsohn U.

J Thromb Haemost. 2003 Apr;1(4):658-61.

35.

Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency.

Salomon O, Zivelin A, Livnat T, Dardik R, Loewenthal R, Avishai O, Steinberg DM, Rosove MH, O'Connell N, Lee CA, Seligsohn U.

Blood. 2003 Jun 15;101(12):4783-8. Epub 2003 Feb 13.

PMID:
12586617
36.

Effects of platelet membrane glycoprotein polymorphisms on the risk of myocardial infarction in young males.

Rosenberg N, Zivelin A, Chetrit A, Dardik R, Kornbrot N, Freimark D, Inbal A.

Isr Med Assoc J. 2002 Jun;4(6):411-4.

37.

Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism.

Salomon O, Rosenberg N, Zivelin A, Steinberg DM, Kornbrot N, Dardik R, Inbal A, Seligsohn U.

Hematol J. 2001;2(1):38-41.

PMID:
11920232
38.

Molecular characterization of four novel mutations causing factor VII deficiency.

Tamary H, Fromovich-Amit Y, Shalmon L, Zaizov R, Yaniv I, Klar A, Peretz H, Brenner B, Lanir N, Zivelin A, Seligsohn U.

Hematol J. 2000;1(6):382-9.

PMID:
11920218
39.

Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene.

Zivelin A, Bauduer F, Ducout L, Peretz H, Rosenberg N, Yatuv R, Seligsohn U.

Blood. 2002 Apr 1;99(7):2448-54.

PMID:
11895778
40.

The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans.

Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E, Seligsohn U.

Am J Hum Genet. 2002 Mar;70(3):758-62. Epub 2002 Jan 4.

41.

Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism.

Streifler JY, Rosenberg N, Chetrit A, Eskaraev R, Sela BA, Dardik R, Zivelin A, Ravid B, Davidson J, Seligsohn U, Inbal A.

Stroke. 2001 Dec 1;32(12):2753-8.

PMID:
11739968
42.

Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia.

Yatuv R, Rosenberg N, Zivelin A, Peretz H, Dardik R, Trakhtenbrot L, Seligsohn U.

Blood. 2001 Aug 15;98(4):1063-9.

PMID:
11493452
43.

Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome.

Mor-Cohen R, Zivelin A, Rosenberg N, Shani M, Muallem S, Seligsohn U.

J Biol Chem. 2001 Oct 5;276(40):36923-30. Epub 2001 Jul 26.

44.

The role of factor XI in thrombin generation induced by low concentrations of tissue factor.

Keularts IM, Zivelin A, Seligsohn U, Hemker HC, B├ęguin S.

Thromb Haemost. 2001 Jun;85(6):1060-5.

PMID:
11434685
45.

Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation.

Dardik R, Varon D, Tamarin I, Zivelin A, Salomon O, Shenkman B, Savion N.

Thromb Haemost. 2000 Feb;83(2):338-44.

PMID:
10739396
46.

Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C.

Zivelin A, Gitel S, Griffin JH, Xu X, Fernandez JA, Martinowitz U, Cohen Y, Halkin H, Seligsohn U, Inbal A.

Blood. 1999 Aug 1;94(3):895-901.

PMID:
10419879
47.

Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy.

Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N, Yassur I, Vidne O, Zivelin A, Gitel S, Davidson J, Ravid B, Seligsohn U.

Ophthalmology. 1999 Apr;106(4):739-42.

PMID:
10201595
48.

ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families.

Nichols WC, Terry VH, Wheatley MA, Yang A, Zivelin A, Ciavarella N, Stefanile C, Matsushita T, Saito H, de Bosch NB, Ruiz-Saez A, Torres A, Thompson AR, Feinstein DI, White GC, Negrier C, Vinciguerra C, Aktan M, Kaufman RJ, Ginsburg D, Seligsohn U.

Blood. 1999 Apr 1;93(7):2261-6.

PMID:
10090935
49.

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.

Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):511-8.

PMID:
10073951
50.

Combined factors V and VIII deficiency--the solution.

Ginsburg D, Nichols WC, Zivelin A, Kaufman RJ, Seligsohn U.

Haemophilia. 1998 Jul;4(4):677-82.

Supplemental Content

Loading ...
Support Center